Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Thrombotic thrombocytopenic purpura associated with clopidogrel

June 16, 2000

Thrombin inhibitors from Merck reported to have nanomolar inhibitory activity

June 14, 2000

Integrin-inhibitory chromenone and chromanone derivatives synthesized at Merck

June 14, 2000

Anticoagulant and antithrombotic effects of PD-200022 reported at ASBMB/ASPET

June 14, 2000

GenStar's new Ad vector for hemophilia A proves safe and effective in murine model

June 13, 2000

AAV-mediated factor IX gene transfer as a therapy for hemophilia B

June 8, 2000

Genentech's single-injection clot buster for heart attack approved by FDA

June 7, 2000

Akzo Nobel's new thrombin inhibitors presented in patent literature

June 6, 2000

Early results from first hemophilia B AAV-mediated gene therapy study

June 6, 2000

Abciximab complements PTCA in patients with AMI

June 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...